Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2025.1729628 Correction Correction: c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity KaboliParham Jabbarzadeh 1 * RoozitalabGhazaal 2 FarghadaniReyhaneh 3 EskandarianZoya 4 ZerrouqiAbdessamad 1 * Conceptualization Formal analysis Funding acquisition Supervision Validation Writing – review & editing Department of Biochemistry, Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Selangor Darul Ehsan, Malaysia Research Institute Children’s Cancer Center, and Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Correspondence: Parham Jabbarzadeh Kaboli, parham.kaboli@wum.edu.pl, pjabbarzadeh@gmail.com; Abdessamad Zerrouqi, abdessamad.zerrouqi@wum.edu.pl 06 11 2025 2025 16 1729628 21 10 2025 24 10 2025 Copyright © 2025 Kaboli, Roozitalab, Farghadani, Eskandarian and Zerrouqi. 2025 Kaboli, Roozitalab, Farghadani, Eskandarian and Zerrouqi https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity By Jabbarzadeh Kaboli P, Roozitalab G, Farghadani R, Eskandarian Z and Zerrouqi A (2024) Front. Immunol. 15:1498391. doi: 10.3389/fimmu.2024.1498391 c-MET immunotherapy PD-L1 cancer galectin CAR-T antibody-drug conjugate section-at-acceptance Cancer Immunity and Immunotherapy

An incorrect number was provided for “National Science Centre, Poland”. The correct number is “2020/39/B/NZ6/03513”.

In the published article, there was a mistake in the funding grant number. The funding grant number was displayed as “2020/39/NZ6/03513”. The correct grant number is “2020/39/B/NZ6/03513’’.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland